Citation Impact
Citing Papers
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation
1995
Rethinking Chronic Allograft Nephropathy
1999
Formation and Function of the Myofibroblast during Tissue Repair
2007 Standout
Renal transplantation following previous heart, liver, and lung transplantation: An 8-year single-center experience
2001
Chimerism of the Transplanted Heart
2002 Standout
Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice
2013 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Epithelial Malignancies in Organ Transplant Patients: Clinical Presentation and New Methods of Treatment
2002
Predictors and Evolution of Renal Function during 9 Years Following Heart Transplantation
2000
Predictors of renal function following lung or heart-lung transplantation
2002
Frequency of hypercholesterolemia after cardiac transplantation
1988
Renal Failure in the Recipients of Nonrenal Solid Organ Transplants
1999
In Situ Detection of Tissue Factor within the Coronary Intima in Rat Cardiac Allograft Vasculopathy
1999
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
2002 Standout
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients
1988
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Skin Cancers after Organ Transplantation
2003 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation
2002
Nontuberculous Mycobacteria in Solid Organ Transplant Recipients
2009
Cardiovascular Toxicities of Immunosuppressive Agents
2002
Immunosuppression switch in pediatric heart transplant recipients: Cyclosporine to FK 506
1995
The medium-term findings in coronary arteries by intravascular ultrasound in infants and children after heart transplantation
2000
Nocardiosis at the Turn of the Century
2009 Standout
RISKS AND COSTS OF END-STAGE RENAL DISEASE AFTER HEART TRANSPLANTATION1,2
1998
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Infections Due to Nontuberculous Mycobacteria in Kidney, Heart, and Liver Transplant Recipients
1994
Molecular regulation of vessel maturation
2003 Standout
Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
1990
CYCLOSPORINE-ASSOCIATED END-STAGE NEPHROPATHY AFTER CARDIAC TRANSPLANTATION
1997
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Coronary arteriosclerosis in pediatric heart transplant survivors: Limitation of long-term survival
1990
INCIDENCE, PROGRESSION AND FUNCTIONAL SIGNIFICANCE OF CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION1
2000
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Characteristics and clinical relevance of chronic anemia in adult heart transplant recipients
2001
DNA methylation-based biomarkers and the epigenetic clock theory of ageing
2018 Standout
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Effect of Pravastatin on Outcomes after Cardiac Transplantation
1995 Standout
Prospective evaluation of peripheral vascular disease in heart transplant recipients
1995
Accelerated coronary vascular disease in the heart transplant patient: Coronary arteriographic findings
1988
Retransplantation for severe accelerated coronary artery disease in heart transplant recipients
1988
Identifying Specific Causes of Kidney Allograft Loss
2009 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Influenza vaccination in heart transplant recipients
1999
Nontuberculous Mycobacterial Infection in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
2004
Infection in Solid-Organ Transplant Recipients
2007 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
Adenovirus-mediated gene transfer of the β2-adrenergic receptor to donor hearts enhances cardiac function
1999 StandoutNobel
Mycobacterium scrofulaceum Infection Presenting as Lung Nodules in a Heart Transplant Recipient
1994
Anemia of Chronic Disease
2005 Standout
Cyclosporine-Induced Hypertension After Transplantation
1994
The Myofibroblast
2007 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
2016 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
The pathobiology of chronic rejection
1989
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
2009 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Infections in solid-organ transplant recipients
1997
Water Microbiology. Bacterial Pathogens and Water
2010 Standout
Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling
2001
Angiotensin II Receptor Antagonist TCV-116 Reduces Graft Coronary Artery Disease and Preserves Graft Status in a Murine Model
1996
Roles of Infectious Agents in Atherosclerosis and Restenosis
1997 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
The role of the lymphatic system in coronary atherosclerosis
1992
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.
1997
Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant Atherosclerosis
1999
The isolation and identification ofMycobacterium aviumcomplex (MAC) recovered from Los Angeles potable water, a possible source of infection in AIDS patients
1994
Effects of Cyclosporine Therapy on Plasma Lipoprotein Levels
1989
Aspergillus fumigatusand Aspergillosis
1999 Standout
Vascular Smooth Muscle Cells in Atherosclerosis
2016 Standout
External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment.
1997
The mechanism of heart failure caused by cardiac allograft rejection
1991
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Hypercholesterolaemia and vascular disease after transplantation
1991 StandoutNobel
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Cytomegalovirus Infection Is Associated With Cardiac Allograft Rejection and Atherosclerosis
1989
Prognostic Importance of Intimal Thickness as Measured by Intracoronary Ultrasound After Cardiac Transplantation
1995
Task force 5: Complications
1993
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of Hunt Sa being referenced
Nontuberculous mycobacterial infections in heart transplant recipients: a seventeen-year experience.
1990
Dermatologic complications following heart transplantation.
1987
The Stanford experience: survival and renal function in the pre-sandimmune era compared to the sandimmune era.
1990
Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection.
1987
Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
1995
Cyclosporine in heart and heart-lung transplantation.
1985
Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient.
1987
Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
1989